These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29894903)
1. Independent effects of age and levodopa on reversal learning in healthy volunteers. Vo A; Seergobin KN; MacDonald PA Neurobiol Aging; 2018 Sep; 69():129-139. PubMed ID: 29894903 [TBL] [Abstract][Full Text] [Related]
2. Levodopa impairs probabilistic reversal learning in healthy young adults. Vo A; Seergobin KN; Morrow SA; MacDonald PA Psychopharmacology (Berl); 2016 Jul; 233(14):2753-63. PubMed ID: 27241710 [TBL] [Abstract][Full Text] [Related]
3. Effects of levodopa on stimulus-response learning versus response selection in healthy young adults. Vo A; Seergobin KN; MacDonald PA Behav Brain Res; 2017 Jan; 317():553-561. PubMed ID: 27743941 [TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. Cools R; Frank MJ; Gibbs SE; Miyakawa A; Jagust W; D'Esposito M J Neurosci; 2009 Feb; 29(5):1538-43. PubMed ID: 19193900 [TBL] [Abstract][Full Text] [Related]
5. The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial. Zunhammer M; Gerardi M; Bingel U Psychopharmacology (Berl); 2018 Sep; 235(9):2587-2595. PubMed ID: 29943093 [TBL] [Abstract][Full Text] [Related]
6. Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning. van der Schaaf ME; van Schouwenburg MR; Geurts DE; Schellekens AF; Buitelaar JK; Verkes RJ; Cools R Cereb Cortex; 2014 Mar; 24(3):633-42. PubMed ID: 23183711 [TBL] [Abstract][Full Text] [Related]
7. Abnormal modulation of reward versus punishment learning by a dopamine D2-receptor antagonist in pathological gamblers. Janssen LK; Sescousse G; Hashemi MM; Timmer MH; ter Huurne NP; Geurts DE; Cools R Psychopharmacology (Berl); 2015 Sep; 232(18):3345-53. PubMed ID: 26092311 [TBL] [Abstract][Full Text] [Related]
8. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study. Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300 [TBL] [Abstract][Full Text] [Related]
10. Levodopa administration modulates striatal processing of punishment-associated items in healthy participants. Wittmann BC; D'Esposito M Psychopharmacology (Berl); 2015 Jan; 232(1):135-44. PubMed ID: 24923987 [TBL] [Abstract][Full Text] [Related]
11. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
12. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
13. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents. Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936 [TBL] [Abstract][Full Text] [Related]
14. Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males. Robinson OJ; Standing HR; DeVito EE; Cools R; Sahakian BJ Psychopharmacology (Berl); 2010 Aug; 211(2):187-95. PubMed ID: 20495788 [TBL] [Abstract][Full Text] [Related]
15. Differential, but not opponent, effects of L -DOPA and citalopram on action learning with reward and punishment. Guitart-Masip M; Economides M; Huys QJ; Frank MJ; Chowdhury R; Duzel E; Dayan P; Dolan RJ Psychopharmacology (Berl); 2014 Mar; 231(5):955-66. PubMed ID: 24232442 [TBL] [Abstract][Full Text] [Related]
16. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [TBL] [Abstract][Full Text] [Related]
17. Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion. Solla P; Fasano A; Cannas A; Mulas CS; Marrosu MG; Lang AE; Marrosu F Parkinsonism Relat Disord; 2015 Aug; 21(8):968-71. PubMed ID: 26071817 [TBL] [Abstract][Full Text] [Related]
18. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Ondo WG; Shinawi L; Moore S Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074 [TBL] [Abstract][Full Text] [Related]
19. Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults. Gallant H; Vo A; Seergobin KN; MacDonald PA Front Neurosci; 2016; 10():374. PubMed ID: 27594823 [TBL] [Abstract][Full Text] [Related]
20. Differential influence of levodopa on reward-based learning in Parkinson's disease. Graef S; Biele G; Krugel LK; Marzinzik F; Wahl M; Wotka J; Klostermann F; Heekeren HR Front Hum Neurosci; 2010; 4():169. PubMed ID: 21048900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]